National Institute of Allergy and Infectious Disease (NIAID)
Phone
301-496-5717866-284-4107
Fax
301-402-3573Website
http://www.niaid.nih.govSummary
The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases. The organization is part of the National Institutes of Health (NIH) and is headquartered in Bethesda, Maryland.
NIAID research priorities include developing: technologies and medical countermeasures against NIAID Category A, B, and C pathogens and emerging infectious diseases; an effective AIDS vaccine; new medical countermeasures for influenza; and better capacity in developing countries to support clinical trials of vaccines and therapeutics for AIDS, malaria, tuberculosis, and other important global diseases.
Work performed in NIAID labs has led to vaccines, treatments, and diagnostic tools and continues to contribute to cutting-edge advances in science technology. NIAID collaborations have led to the development of FDA-approved vaccines for influenza (FluMist), hepatitis A (Havrix), and rotavirus (RotaShield).